Abbott Laboratories [NYSE: ABT] loss -0.55% on the last trading session, reaching $133.7 price per share at the time.
Abbott Laboratories represents 1.74 billion in outstanding shares, while the company has a total market value of $232.62 billion with the latest information. ABT stock price has been found in the range of $132.85 to $134.91.
If compared to the average trading volume of 6.74M shares, ABT reached a trading volume of 8919818 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Abbott Laboratories [ABT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABT shares is $143.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Abbott Laboratories shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on October 08, 2024, representing the official price target for Abbott Laboratories stock. Previously, the target price had yet another raise to $131, while Piper Sandler analysts kept a Overweight rating on ABT stock.
The Price to Book ratio for the last quarter was 4.77, with the Price to Cash per share for the same quarter was set at 3.93. Price to Free Cash Flow for ABT in the course of the last twelve months was 34.94 with Quick ratio for the last quarter at 1.27.
Trading performance analysis for ABT stock
Abbott Laboratories [ABT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.51. With this latest performance, ABT shares gained by 0.56% in over the last four-week period, additionally plugging by 18.20% over the last 6 months – not to mention a rise of 18.20% in the past year of trading.
Abbott Laboratories [ABT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Abbott Laboratories [ABT] shares currently have an operating margin of 16.96% and a Gross Margin at 51.42%. Abbott Laboratories’s Net Margin is presently recorded at 31.72%.
Return on Equity for this stock inclined to 17.45%, with Return on Assets sitting at 17.45%.
Abbott Laboratories [ABT]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbott Laboratories go to 10.36%.
An analysis of Institutional ownership at Abbott Laboratories [ABT]
There are presently around $80.49%, or 80.93% of ABT stock, in the hands of institutional investors. The top three institutional holders of ABT stocks are: VANGUARD GROUP INC with ownership of 166.35 million shares, which is approximately 9.5932%. BLACKROCK INC., holding 131.13 million shares of the stock with an approximate value of $$13.63 billion in ABT stocks shares; and BLACKROCK INC., currently with $$7.73 billion in ABT stock with ownership which is approximately 4.2903%.
